Analysed NXERA PHARMA CO LTD (SOLTF:OTCMKTS) News Sources
Notice of Issuance of New Shares in Connection with the Introduction of the Employee Stock Ownership Plan, Matters Relating to Stock Units and Determination of Payment Amount and Other Matters of Issuance of New Shares Under Prior RSU Award
15-04-2026
yahoo.com
Nxera Pharma’s QUVIVIQ® (daridorexant) 25mg and 50mg Receives Approval in Taiwan for the Treatment of Insomnia
14-04-2026
yahoo.com
Nxera Pharma’s Partner Neurocrine Biosciences Doses First Patient in Phase 2 Trial of NBI-1117570 for Adults with Schizophrenia
12-04-2026
yahoo.com
Nxera Pharma Achieves Second Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases
08-04-2026
yahoo.com
Nxera Pharma to Receive US$3 Million Milestone Payment from Centessa Pharmaceuticals
05-03-2026
yahoo.com
Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea
04-03-2026
yahoo.com
What is the current price of NXERA PHARMA CO LTD (SOLTF:OTCMKTS)?
The current price of NXERA PHARMA CO LTD (SOLTF:OTCMKTS) is $6.53.
NXERA PHARMA CO LTD (SOLTF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of NXERA PHARMA CO LTD (SOLTF:OTCMKTS) since the previous trading day is $1.25.
NXERA PHARMA CO LTD (SOLTF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of NXERA PHARMA CO LTD (SOLTF:OTCMKTS) since the previous trading day is 23.6742%.
What is the most recent average sentiment score for NXERA PHARMA CO LTD (SOLTF:OTCMKTS)?
The most recent average sentiment score for NXERA PHARMA CO LTD (SOLTF:OTCMKTS) is 77 out of 100.
What is the most recent average sentiment for NXERA PHARMA CO LTD (SOLTF:OTCMKTS)?
The most recent sentiment for NXERA PHARMA CO LTD (SOLTF:OTCMKTS) is .
SEC-8K** Filing Available For NXERA PHARMA CO LTD (SOLTF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.